Arcoma AB

kr 8.50As of Sun 8 Nov 2026, 12:00 UTC
STO:ARCOMAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 7.57%
Div yield —
ROE 6.44%
Medical Devices
Beta (5Y) 0.70
PE TTM 24.93
TSR TTM 4.94%
Mkt cap kr 121.6M
ROIC 9.94%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 11
25.05%
(43.30%)
Hold 4|3|1|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.13
0.13
0.13
0.13
31.92%
31.04%
20.90%
8.68%
Revenuekr M
8.931
9.117
9.486
9.608
1.26%
0.71%
4.51%
8.77%
Peers (US$12.30M)
Cap (US$)
PE
11.18M
—
10.21M
—
Capital
TTM
5Y
10Y
Leveragex
0.184
0.388
0.309
EBIT/Intx
0.824
0.679
0.562
Own earn%
(849.86)
(39.92)
(53.27)
Sh yield%
52.05
23.70
25.78
Owners
Insiders/Inst%
11.82
36.46
Short interest%
3.77
SBC / revenue%
1.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
14–20
$1 testx
0.0
Incr. ROIC%
2